About Us

I made this for my mother.

My name is Cyrus. I have a background in biology — the kind where you actually read the research, not just the label.

For years I watched my mother (unfortunately cursed with both diabetes, and arthritis) cycle through every joint and nerve cream on the market . Menthol. Camphor. Magnesium sprays. Diclofenac gel. Each one gave her just enough relief to create hope, and wore off fast enough to kill it. She stopped complaining about it eventually. She just quietly stopped doing the things that hurt.

That's when I decided I couldn't just watch anymore.

What I found when I actually looked.

The topical pain category hasn't changed much in decades. The same handful of actives — recycled, repackaged, re-promised. Nobody seemed to be asking the obvious question: are we even targeting the right tissue?

Joint pain doesn't live in your skin. It lives in the periarticular space — the soft tissue, connective tissue, and inflamed nerve endings that surround the joint. When most creams cool your skin, they're not touching the source. They're distracting you from it.

I spent months going through the primary literature until I found the ingredient that kept coming up and kept getting ignored by every major brand: devil's claw.

The plant nobody put in a cream.

Harpagophytum procumbens grows in the Kalahari Desert and has been used in southern African traditional medicine for centuries. Its active compounds — iridoid glycosides, particularly harpagoside — don't work the way menthol works. The evidence points to genuine COX and LOX anti-inflammatory activity. The same pathways pharmaceutical NSAIDs target. Without the systemic absorption risks.

The problem with most "natural" topicals isn't the plant. It's the dose. You can't put a trace of something in a cream and call it active.

Herbavera uses a 5:1 concentrated devil's claw extract standardized to 2% harpagosides, HPLC-verified. That's not a marketing phrase. It's a specification — a known, consistent amount of the compound that does the actual work.

Why three ingredients, not one.

Devil's claw alone wasn't enough. What makes Herbavera different is the combination:

Devil's Claw (5:1, 2% harpagosides) — COX-2 inhibition. Targets the inflammatory cascade at tissue level.

Boswellia Serrata (5:1, 65% boswellic acids, 10% AKBA) — 5-LOX inhibition. A completely separate inflammatory pathway that COX inhibitors don't touch. AKBA is the most potent compound in the boswellic family, and almost no topical on the market uses it at a meaningful standardized dose.

Arnica Montana (5:1, standardized sesquiterpene lactones) — Reduces local microvascular inflammation and tissue swelling in the periarticular space. Addresses the physical swelling that compounds both joint and nerve pain.

Block both pathways simultaneously. Support the tissue around the joint. That's the mechanism. It builds with consistent use — week two typically feels different than day one. We tell you that upfront because we'd rather you know what to expect than oversell a first application.

Who this is for.

People who've already tried four other things. People who are done with vague promises and want to know what's actually in the jar and why. People whose doctors said "learn to live with it" and decided that wasn't an answer.

It's for my mother. It kept finding more people like her.

90-day guarantee. No fine print. If it doesn't work for you, we don't want your money.

— Cyrus, Founder